Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations

Authors:

Abstract
No abstract available
Funding Information
  • Medical University of South Carolina (UL1TR001450)
  • Cystic Fibrosis Foundation Therapeutics (NICKR0)
  • Cystic Fibrosis Foundation Therapeutics (FLUME13A1)
  • Cystic Fibrosis Foundation Therapeutics (HELTSH13A1)
  • Cystic Fibrosis Foundation Therapeutics (SANDERS14A0)
  • Cystic Fibrosis Foundation Therapeutics (DAINES14Y0)
  • Cystic Fibrosis Foundation Therapeutics (GOSS13A0)
  • Cystic Fibrosis Foundation Therapeutics (CLANCY09Y0)
  • Cystic Fibrosis Foundation Therapeutics (ORENST14Y0)
  • National Institutes of Health (P30 DK089507)
  • National Institutes of Health (KL2 TR000428)
  • National Institutes of Health (UL1 TR000427)
  • University of Wisconsin-Madison
  • South Carolina Clinical and Translational Research Institute, Medical University of South Carolina

This publication has 33 references indexed in Scilit: